Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review.

2-dimensional echocardiography 3-dimensional echocardiography heart failure with preserved ejection fraction left atrial fibrosis left atrium left ventricular diastolic function phasic function speckle-tracking echocardiography volumes

Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
23 04 2019
Historique:
received: 24 12 2018
accepted: 15 01 2019
entrez: 20 4 2019
pubmed: 20 4 2019
medline: 5 3 2020
Statut: ppublish

Résumé

Defining left atrial (LA) function has recently emerged as a powerful parameter, particularly in evaluation of left ventricular (LV) diastolic dysfunction (LVDD) and heart failure with preserved ejection fraction. Echocardiographic assessment of LVDD by echocardiography remains a challenging task; recent recommendations provide a simpler approach than previous. However, the shortcomings of the proposed approach (including transmitral flow, tissue velocity, maximum left atrial volume [LAV], and estimated pulmonary artery systolic pressure), lead to the presence and severity of LVDD remaining undetermined in a significant proportion of patients. Maximum LAV is a surrogate measure of the chronicity and severity of LVDD, but LAV alone is an insensitive biomarker of early phases of LVDD, because the LA may take time to remodel. Because the primary function of the LA is to modulate LV filling, it is not surprising that functional LA changes become evident at the earliest stages of LVDD. Moreover, LA function may provide additive value, not only in diagnosing LVDD, but also in grading its severity and in monitoring the effects of treatment. The current review provides a critical appraisal on the existing evidence for the role of LA metrics in evaluation of LVDD and consequent heart failure with preserved ejection fraction.

Identifiants

pubmed: 31000000
pii: S0735-1097(19)33696-4
doi: 10.1016/j.jacc.2019.01.059
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1961-1977

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. All rights reserved.

Auteurs

Liza Thomas (L)

University of Sydney, Sydney, NSW, Australia; Department of Cardiology Westmead Hospital; South West Clinical School, University of New South Wales, Sydney, NSW, Australia. Electronic address: liza.thomas@sydney.edu.au.

Thomas H Marwick (TH)

Baker IDI heart and Diabetes Institute and the Alfred Hospital, Melbourne, Victoria, Australia.

Bogdan A Popescu (BA)

University of Medicine and Pharmacy "Carol Davila"-Euroecolab, Department of Cardiology, Institute of Cardiovascular Diseases "Prof. Dr. C. C. Iliescu," Bucharest, Romania.

Erwan Donal (E)

University of Rennes, CHU Rennes, Inserm, LTSI-UMR 1099, Rennes, France.

Luigi P Badano (LP)

University of Milano-Bicocca, Milan, Italy; IRCCS, Istituto Auxologico Italiano, S. Luca Hospital, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH